v3.26.3
Commitments and Contingencies (Details) - USD ($)
9 Months Ended
Oct. 28, 2025
Sep. 30, 2026
Oct. 29, 2025
Commitments and Contingencies [Line Items]      
Number of transfer period   180 days  
Forfeited remaining unexercised balance   30,000  
Underwriters option period   45 days  
Deferred underwriting fee   $ 13,788,000  
Due to underwriters unit   $ 0.4  
Private Placement Warrants [Member]      
Commitments and Contingencies [Line Items]      
Converted shares   1,500,000  
Working capital loans   $ 1,500,000  
Private placement warrants   8,894,000  
Warrant [Member]      
Commitments and Contingencies [Line Items]      
Converted shares   10,394,000  
Over-Allotment Option [Member]      
Commitments and Contingencies [Line Items]      
Purchase units shares 4,470,000    
Initial Public Offering [Member]      
Commitments and Contingencies [Line Items]      
Underwriting fees deferred   $ 6,894,000  
Purchase of additional units   4,500,000  
Underwriters [Member]      
Commitments and Contingencies [Line Items]      
Underwriting discount per unit   $ 0.2  
Deferred fee price per unit   $ 0.4  
Deferred underwriting fee   $ 13,788,000  
Registration Rights Agreement [Member] | Private Placement Warrants [Member]      
Commitments and Contingencies [Line Items]      
Private placement warrants   8,894,000  
Class A Ordinary Shares [Member]      
Commitments and Contingencies [Line Items]      
Converted shares   21,884,000  
Conversion of shares issued   11,490,000  
Class A Ordinary Shares [Member] | Private Placement Warrants [Member]      
Commitments and Contingencies [Line Items]      
Units underlying shares   8,894,000  
Warrants shares issued   1,500,000  
Class A Ordinary Shares [Member] | Initial Public Offering [Member]      
Commitments and Contingencies [Line Items]      
Private placement warrants   26,129,000  
Class A Ordinary Shares [Member] | Initial Public Offering [Member] | Private Placement Warrants [Member]      
Commitments and Contingencies [Line Items]      
Private placement warrants     8,894,000